Since posting my rant on the now age old debate about paternalism (or as the people over in USA are calling it: Nanny State) versus public health, I have been reading a lot more about the Soda wars and it emerges that now it is way more hotly debated than ever before. Following in the steps of Mayor Bloomberg, Mississippi Senator Tony Smith has authored … Continue reading Anti-Bloomberg Bill in the Soda Wars: Two Wrongs do not Make a Right!
I have been known to lament the loss of the prestige of the basic medical degree (MBBS) in India. While you may or may not agree with it, the truth remains that nobody who is doing (or has recently done) an MBBS course wants to stay out at that level. Everyone wants to go and be a specialist or super-specialist. In the melee of confusion … Continue reading The Family Physician: A Dying Romantic Idea
I have pretty much been declared the official (Indian) USMLE rumor-monger by one of the most famous USMLE coaching institutes that held introductory classes to tell the masses what USMLE was all about. Thank you sir, you made my day. Now, again, another disclaimer. The last time I wrote about the USMLE match (this one: The USA Dream for IMGs: Coming to an end? Analyzing … Continue reading USMLE 2013 and IMGs: All That Glitters is NOT Gold
Paternalistic attitude in unilateral implementation of public health policies, especially with respect to banning of (harmful) substances, has been one of the issues that I have been debating not only with my colleagues, but also with my own self, for a while now. Aside from the obvious stake in the matter as a student of Public Health and Community Medicine, this has been an issue … Continue reading New York Soda Rule: Raising the Debate on Paternalism in Public Health
When TechCrunch reported that there were talks going on between Elsevier and Mendeley this January, I did not want to believe it. Being an ardent user and advocate of the platform, I wanted it to stay out of the clutches of Big Pub. But it is now official, Mendeley has been acqui-hired by Elsevier for an unknown amount, which could be anything from65-100 million US … Continue reading Another Start-up Bites the Dust: Elsevier Buys Mendeley